New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...
New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...
New Vaccine Post-Introduction Evaluation - libdoc.who.int - World ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1. Overview<br />
1.1 <strong>Introduction</strong><br />
This post-<strong>int</strong>roduction evaluation (PIE) tool provides a systematic method for<br />
evaluating the impact of the <strong>int</strong>roduction of a vaccine on the existing immunization<br />
system in a country. The PIE tool is designed for immunization managers in countries<br />
that have <strong>int</strong>roduced a new or underutilized vaccine. WHO recommends that all<br />
countries which have <strong>int</strong>roduced a new vaccine conduct a PIE. Conducting a PIE is<br />
not a new concept, and there are several examples of evaluations of Hepatitis B (HepB)<br />
and Haemophilus influenzae type b (Hib) vaccine <strong>int</strong>roductions — those experiences<br />
have been incorporated <strong>int</strong>o this tool. The purpose of the current tool is to provide a<br />
systematic method of performing the evaluation, that is comparable across countries,<br />
to facilitate the sharing of experiences. Numerous WHO and UNICEF guidelines<br />
and operational manuals have been consulted in the preparation of the tool, which is<br />
suitable for evaluation of all new vaccines but will require revision for each country’s<br />
individual circumstances, and for the different vaccine formulations and presentations.<br />
This manual consists of an overview of the PIE, a description of what needs to be<br />
evaluated and what the evaluator should be looking for, and an explanation of how to<br />
synthesize the data and present the findings.<br />
1.2 What are the goals of the manual?<br />
The manual has four major objectives.<br />
1) To provide health ministries and immunization partners with user-friendly tools<br />
to conduct a comprehensive evaluation of the impact of the <strong>int</strong>roduction of a<br />
new vaccine on their immunization programmes.<br />
2) To provide recommendations for rectifying typical problems associated with the<br />
<strong>int</strong>roduction of a new vaccine.<br />
3) To provide guidance for analysis of data collected during the evaluation.<br />
4) To provide a template for a final report.<br />
WHO/IVB/10.03<br />
1